Strong growth
of strong growth
Intervening in France, Europe and internationally
The problems of isolation, access to care, and lack of sanitary facilities, while essential in France, are vital for many countries in the world, particularly in Africa and Latin America.
In response to structural deficiencies in healthcare models, telemedicine has experienced a meteoric rise and digital health has become the most attractive business sector. Loxamed is one of the players behind this movement in France and it wishes to reinforce these transformations by further developing its mission of proximity health́. It has alreadỳ built with all of its partners medical, mobile, modular, connected, operational and secure solutions to facilitate access to care, fluidify medical processes, act preventively by training, screening, diagnosing and vaccinating.
Loxamed is structured to develop in both the public and private sectors and wishes to further expand in Europe and worldwide.
Frost & Sullivan estimates that the global digital health market will be worth $234.5 billion by 2023, up 160% from 2019. This growth, which is mainly due to needs related to the aging population and the sharp increase in chronic diseases.
The rise of telemedicine in France
and in the world
In France, teleconsultations have exploded since the first pandemic lockdown (x16 in 6 months), thanks in particular to improved legal constraints on reimbursement. Globally, the teleconsultation market has more than doubled in 5 years, with an estimated $41.2 billion in 2021, compared to $20.2 billion in 20161. It is estimated to be worth around €5 billion in France over the next five years2.
Before the Covid-19 pandemic and since 2018, some teleconsultations were reimbursed when they met certain specific criteria: the practitioner must alreadỳ know the patient; the care pathway must be respected. Telemedicine encompasses different acts, for which Loxamed offers many solutions: teleconsultation, tele-expertise, remote monitoring, remote assistance, medical response provided in the context of medical regulation. During the Covid-19 pandemic, telemedicine demonstrated́ that it was a major asset to protect the health of the greatest number.
1. Source: Statista
2. Sources: Institut Montaigne / McKinsey & Company
3. Source: "Le Nouvel Économiste
Containment has made it possible to change the regulations so that
that all teleconsultations are reimbursed by the health insurance, especially if the practitioner does not know the patient.
Over the last week of April 2020 and due to the pandemic arrangements, Medicare in France recorded 1 million teleconsultations compared to 10,000 in early March. 4.5 million teleconsultations occurred in the entire month of April alone, compared to 75,000 in 2019. The number of teleconsultations rises to 1.9 million in November 2020.
In the medium term, 15-25% of physical consultations could shift to teleconsultation. This could reduce the number of daily trips by half a million (out of a total of 43 million) in Île-de-France3.
Number of patients using teleconsultation
(in October 2020 compared to the pre-pandemic period)
Number of practitioners using teleconsultation
(in October 2020 compared to the pre-pandemic period)
Global telemedicine market in 2021
Loxamed expands in West Africa
FIRST STEP, RWANDA
Loxamed was among the companies invited by the MEDEF on October 26 and 27, 2021. The opportunity for the Loxamed team, led by its Managing Director, Matthieu Guillotin, and accompanied by Cedric Lacour, Sales & Marketing Director and Dr. François Teboul from Télédok, to meet the Rwandan authorities.
With Franck Riester, Minister Delegate to the Minister of Europe and Foreign Affairs, in charge of Foreign Trade and Attractiveness.
With the Rwandan Minister of Health Daniel Ngamije.
The mobile medical solutions proposed by Loxamed will be installed initially in the capital Kigali before being deployed throughout the country.